Citations

Showing 10 of 108104 citations.

Sulfonylureas and Mortality in Diabetic Patients After Myocardial Infarction
Brady, Peter A. , Kopecky, Stephen L. , Suwaidi, Jassim Al , Terzic, André

Mayo Clinic

Circulation | September 30, 2018 | Volume: 97 | Issue: 7 | Pages: No page available

10.1161/circ.97.7.709/a Get It

Poor performance of psoas muscle index for identification of patients with higher waitlist mortality risk in cirrhosis
Wang, Connie W. , Dunn, Michael A. , Carey, Elizabeth J. , Ebadi, Maryam , Lai, Jennifer C. , Dasarathy, Srinivasan , Kappus, Matthew R. , Montaño‐Loza, Aldo J.

Mayo Clinic

Journal of Cachexia, Sarcopenia and Muscle | September 30, 2018 | Volume: 9 | Issue: 6 | Pages: 1053-1062

10.1002/jcsm.12349 | PMID 30269421 Get It

AbstractBackgroundSarcopenia, characterized by low muscle mass, associates with mortality in patients with cirrhosis. Skeletal muscle area in a single computed tomography image at the level of the third lumbar vertebrate (L3) is a valid representative of whole body muscle mass. Controversy remains regarding applicability of psoas muscle to identify patients at greater risk of mortality. We aimed to determine psoas muscle index (PMI) association with skeletal muscle index (SMI) and to evaluate the capacity of PMI to predict liver transplant waitlist mortality.MethodsWe evaluated listed adult patients with cirrhosis from 2012 to 2013 at four North American liver transplant centres. From L3 computed tomography images within 3 months of listing, we determined SMI and PMI expressed by cm2/m2. Low SMI was defined as SMI <39 cm2/m2 in women and <50 cm2/m2 in men as published by us earlier. Cut‐offs for PMI to predict mortality were established using a receiver‐operating characteristic analysis. Mortality predictors were determined using competing‐risk analysis with reported results as subdistribution hazard ratios (sHRs).ResultsOf 353 waitlist candidates, 68% were men, mean age 56 ± 9 years, and Model for End‐stage Liver Disease of 16 ± 8 points. Low SMI was present more frequently in men than women (51 vs. 36%, P = 0.02). Moderately strong correlation between SMI and PMI was observed (r > 0.7, P < 0.001). Low PMI (males < 5.1 cm2/m2; females < 4.3 cm2/m2) yielded poor and moderate concordance with low SMI in men and women, respectively (Kappa coefficient 0.31 and 0.63). SMI (39 ± 9 vs. 43 ± 7 cm2/m2; P = 0.009) and PMI (4.4 ± 1.3 vs. 5.2 ± 1.1 cm2/m2; P = 0.001) were lower in women who died and/or were delisted (compared with non‐deceased patients) whereas men who died and/or were delisted had only lower SMI (47 ± 7 vs. 51 ± 9 cm2/m2; P = 0.003), but not PMI compared with non‐deceased patients. In women, both SMI (sHR 0.94, P = 0.048) and PMI (sHR 0.58, P = 0.002) were predictors of mortality, while in men, SMI was significant (sHR 0.95, P = 0.001) and PMI showed a trend to be (sHR 0.85, P = 0.09) associated with mortality. Overall, 104 patients (29%) were misclassified between SMI and PMI categories. Using PMI cut‐offs, 66% and 28% of low SMI men and women, who have a higher risk of mortality, were incorrectly classified as low risk.ConclusionsSkeletal muscle index is a more complete and robust measurement than PMI, especially in men with cirrhosis. Low PMI identifies an incomplete subset of patients at increased risk of mortality indicated by low SMI. Given the poor performance of PMI, SMI should not be substituted by PMI.
Task Force 3: Disclosure of Relationships With Commercial Interests: Policy for Educational Activities and Publications
Lindsay, Bruce D., Bellande, Bruce J., Nishimura, Rick A., Shah, Pravin M., Jackson, Marcia, Rahimtoola, Shahbudin H., Jacobs, Alice K. , Fonarow, Gregg C. , Annex, Brian Herb , Fuster, Valentı́n , Gibbons, Raymond J.

Mayo Clinic

Circulation | September 29, 2018 | Volume: 110 | Issue: 16 | Pages: 2524-2528

10.1161/circ.110.16.2524 Get It

Task Force 1: The ACCF and AHA Codes of Conduct in Human Subjects Research
Alpert, Joseph S., Shine, Kenneth I., Adams, Robert J. , Kavey, R E, Friedman, Lawrence M., Frye, Robert L. , Harrington, Robert A. , Korn, David, Antman, Elliott M. , Merz, Jon F. , Ofili, Elizabeth

Mayo Clinic

Circulation | September 29, 2018 | Volume: 110 | Issue: 16 | Pages: 2512-2516

10.1161/circ.110.16.2512 Get It

Innervation of the anconeus epitrochlearis muscle: MRI and cadaveric studies
Collin, Peter G., Ishak, Basem , Iwanaga, Joe , Amrami, Kimberly K. , Ringler, Michael D. , Ruiter, Godard C. W. de , Spinner, Robert J. , Tubbs, R. Shane , Tubbs, R Shane , Iwanaga, Joe , Grewal, Sanjeet S.

Mayo Clinic

Clinical Anatomy | September 29, 2018 | Volume: 32 | Issue: 2 | Pages: 218-223

10.1002/ca.23285 | PMID 30267439 Get It

Ulnar neuropathy at the cubital tunnel is common. However, a rare form of ulnar neuropathy here is due to compression from an accessory muscle, the anconeus epitrochlearis. Reports in the literature regarding the details of this muscle's innervation are vague, so the aim of the present study was to characterize this anatomy more clearly. This was a combined review of magnetic resonance imaging (MRI) from patients with an anconeus epitrochlearis and ulnar neuropathy and cadaveric dissections to characterize the innervation of this variant muscle. A review of 11 patients and three reports of ulnar neuropathy and an anconeus epitrochlearis in the literature revealed no MRI changes consistent with acute denervation of this muscle. However, in two cases, there were signs of chronic denervation of the muscle. Dissection of five cadavers revealed that the nerve supply to the anconeus epitrochlearis originated proximal to the medial epicondyle, traveled parallel to the ulnar nerve, terminated on the deep aspect of this muscle, and had a mean length of 60 mm. This clinicoanatomical study provides evidence that the innervation of the anconeus epitrochlearis is proximal to the muscle and on its deep aspect. Clin. Anat. 32:218–223, 2019. © 2018 Wiley Periodicals, Inc.
Early Complications and Mortality following Radical Cystectomy: Associations with Malnutrition and Obesity
Hanson, Kristine T. , Habermann, Elizabeth B. , Tollefson, Matthew K. , Habermann, Elizabeth , Arora, Karan , Psutka, Sarah P. , Hanson, Kristine

Mayo Clinic

Bladder Cancer | September 29, 2018 | Volume: 4 | Issue: 4 | Pages: 377-388

10.3233/blc-180173 | PMID 30417048 Get It

Background: There are conflicting data regarding the impact of obesity on postoperative outcomes following radical cystectomy (RC) and how obesity and malnutrition interact in patients undergoing RC. Objective: To evaluate associations of body mass index (BMI), significant preoperative weight loss, and hypoalbuminemia with 30-day complications and mortality after RC. Methods: Review of the American College of Surgeons National Surgical Quality Improvement Program database identified 2,055 patients who underwent RC (2006-12). Univariate and multivariable logistic regression models were developed to assess associations between hypoalbuminemia (<3.5 g/dL), >10% preoperative weight loss, obesity as characterized by BMI (class I: 30–34.9, II: 35–39.9, III: ≥40 kg/m 2 ), and 30-day complications and mortality. Results: The median BMI of the study cohort was 27.82 kg/m 2 with 22.4% classified as having class I, 7.5% class II, and 4.2% class III obesity, respectively. Hypoalbuminemia and >10% weight loss were present in 16.7% and 3.5%, respectively. Among obese patients, 13.4% had hypoalbuminemia. On multivariable analysis, class I (OR 1.43, p = 0.01), class II (OR 1.92, p < 0.001), and class III (OR 2.32, p < 0.001) obesity and hypoalbuminemia (OR 1.47, p = 0.02) were independently associated with 30-day complications, and class III obesity (OR 2.96, p = 0.02) and hypoalbuminemia (OR 2.33, p = 0.03) were independently associated with 30-day mortality. Conclusion: Increasing class of obesity and hypoalbuminemia were independently associated with increased complications following RC. Hypoalbuminemia and class III obesity were associated with early mortality. This study highlights the fact that malnutrition may coexist in obese patients and underscores the need to identify patients with malnutrition who may be candidates for preoperative nutritional optimization.
Outcomes after carotid endarterectomy among elderly dual Medicare-Medicaid–eligible patients
Leifheit, Erica C , Wang, Yun , Howard, George , Howard, Virginia J. , Goldstein, Larry B. , Brott, Thomas G. , Lichtman, Judith H. , Howard, Virginia J , Howard, George

Mayo Clinic

Neurology | September 29, 2018 | Volume: 91 | Issue: 17 | Pages: No page available

10.1212/wnl.0000000000006380 | PMID 30266891 Get It

Equivalent Outcomes With Retransplantation and Primary Liver Transplantation in the Direct-acting Antiviral Era
Croome, Kristopher P. , Mathur, Amit K. , Pungpapong, Surakit , Lee, David D. , Moss, Adyr A. , Rosen, Charles B. , Taner, C. Burcin , Croome, Kris P , Lee, David D , Pungpapong, Surakit , Heimbach, Julie K.

Mayo Clinic

Transplantation | September 29, 2018 | Volume: 103 | Issue: 6 | Pages: 1168-1174

10.1097/tp.0000000000002460 | PMID 30247315 Get It

Background. The present multicenter study investigated whether equivalent outcomes to primary liver transplant (LT) could be achieved with liver retransplant (reLT) and whether improvements in outcomes have taken place over time, particularly in the direct-acting antiviral era. Methods. All reLT performed at Mayo Clinic Florida, Mayo Clinic Rochester, and Mayo Clinic Arizona were divided into era 1 (2002–2007), era 2 (2008–2012), and era 3 (2013–2017) based on the date of reLT. Results. Improvement in graft survival (GS) after reLT was seen over the 3 eras (P < 0.001). In era 1, GS after reLT was inferior to primary LT (P < 0.001), whereas no difference was seen between reLT and primary LT in era 2 (P = 0.68) or era 3 (P = 0.36). A significantly higher proportion of patients achieved sustained viral response (SVR) within the first year after reLT in each subsequent era (era 1: 10.3%, era 2: 22.5%, and era 3: 100%) (P < 0.001). Graft survival was superior in patients undergoing reLT for recurrent hepatitis C virus who achieved SVR after reLT compared with those who did not (P = 0.03). Conclusions. Results similar to primary LT were achieved in era 3. These improvements coincide with the availability of direct-acting antivirals, which resulted in a 100% SVR rate in era 3 and a decrease in the number of patients undergoing reLT for recurrent hepatitis C virus. The historic dogma that reLT results in inferior outcomes should be revisited.
Kidney Transplant in the Era of Modern Therapy for Multiple Myeloma
Huskey, Janna L. , Heilman, Raymond L. , Khamash, Hasan , Fonseca, Rafaël

Mayo Clinic

Transplantation | September 29, 2018 | Volume: 102 | Issue: 12 | Pages: 1994-2001

10.1097/tp.0000000000002449 | PMID 30211830 Get It

Abstract Chronic kidney disease is common in patients with multiple myeloma. Historically, individuals with end-stage renal disease and multiple myeloma did poorly with renal transplantation due to higher mortality rates from the malignancy itself or associated comorbidities. However, over the past 2 decades, there have been significant advances in the treatment of multiple myeloma with the advent of new therapeutic agents resulting in an improvement of long-term survival. As a result, more individuals with multiple myeloma are being referred for kidney transplantation, especially those with good functional capacity and minimal comorbidities. Recent literature has suggested that certain patients with multiple myeloma can successfully undergo renal transplantation after stem transplantation with consideration for maintenance therapy, although caution should be used with immunomodulating drugs due to the anecdotally reported risk of acute rejection. Therefore, having a multidisciplinary approach with the transplant team and hematology both before and after transplant is crucial in maximizing the chance of success for these individuals. This review summarizes the literature on renal transplantation in patients with multiple myeloma as well as the therapeutic advancements that have occurred which may allow certain patients to undergo successful transplantation.
Pilot Survey of Female Anesthesiologists’ Childbearing and Parental Leave Experiences
Pearson, Amy C. S. , Dodd, Sarah E. , Kraus, Molly B. , Ligda, Kristin M. Ondecko, Hertzberg, Linda B., Patel, Perene V., Chandrabose, Rekha K. , Pearson, Amy C S , Kraus, Molly B , Ligda, Kristin Ondecko

Mayo Clinic

Anesthesia & Analgesia | September 29, 2018 | Volume: 128 | Issue: 6 | Pages: e109-e112

10.1213/ane.0000000000003802 | PMID 31094811 Get It

While the literature regarding physicians’ childbearing experiences is growing, there are no studies documenting those of anesthesiologists. We surveyed a convenience sample of 72 female anesthesiologists to obtain pilot data. Sixty-six women completed the survey (91.7% response rate), reporting 113 total births from before 1990 to present. Of all birth experiences, proportions of respondents reporting parental leave, lactation facilities, and lactation duration as adequate were 52.3%, 45.2%, and 58.3%, respectively. Most mothers (51.8%) gave birth to their first child while they were trainees. The majority (94.9%) favored an official statement supporting parental leave. These results may serve as groundwork for larger studies.